These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23585760)

  • 1. The destructive negative binomial cure rate model with a latent activation scheme.
    Cancho VG; Bandyopadhyay D; Louzada F; Yiqi B
    Stat Methodol; 2013 Jul; 13():48-68. PubMed ID: 23585760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cure rate survival model under a hybrid latent activation scheme.
    Borges P; Rodrigues J; Louzada F; Balakrishnan N
    Stat Methods Med Res; 2016 Apr; 25(2):838-56. PubMed ID: 23264557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Destructive weighted Poisson cure rate models.
    Rodrigues J; de Castro M; Balakrishnan N; Cancho VG
    Lifetime Data Anal; 2011 Jul; 17(3):333-46. PubMed ID: 21076872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Bayesian destructive weighted Poisson cure rate model and an application to a cutaneous melanoma data.
    Rodrigues J; Cancho VG; de Castro M; Balakrishnan N
    Stat Methods Med Res; 2012 Dec; 21(6):585-97. PubMed ID: 21131689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Non-Linear Conjugate Gradient Algorithm for Destructive Cure Rate Model and a Simulation Study: Illustration with Negative Binomial Competing Risks.
    Pal S; Roy S
    Commun Stat Simul Comput; 2022; 51(11):6866-6880. PubMed ID: 36568126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new cure rate model with flexible competing causes with applications to melanoma and transplantation data.
    Leão J; Bourguignon M; Gallardo DI; Rocha R; Tomazella V
    Stat Med; 2020 Oct; 39(24):3272-3284. PubMed ID: 32716081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cure rate models for heterogeneous competing causes.
    Brandão M; Leão J; Gallardo DI; Bourguignon M
    Stat Methods Med Res; 2023 Sep; 32(9):1823-1841. PubMed ID: 37489264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of frailties into a cure rate regression model and its diagnostics and application to melanoma data.
    Leão J; Leiva V; Saulo H; Tomazella V
    Stat Med; 2018 Dec; 37(29):4421-4440. PubMed ID: 30109718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simplified stochastic EM algorithm for cure rate model with negative binomial competing risks: An application to breast cancer data.
    Pal S
    Stat Med; 2021 Dec; 40(28):6387-6409. PubMed ID: 34783093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On a reparameterization of a flexible family of cure models.
    Milienos FS
    Stat Med; 2022 Sep; 41(21):4091-4111. PubMed ID: 35716033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A flexible family of transformation cure rate models.
    Koutras MV; Milienos FS
    Stat Med; 2017 Jul; 36(16):2559-2575. PubMed ID: 28417477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Likelihood inference for COM-Poisson cure rate model with interval-censored data and Weibull lifetimes.
    Pal S; Balakrishnan N
    Stat Methods Med Res; 2017 Oct; 26(5):2093-2113. PubMed ID: 28656795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On a class of non-linear transformation cure rate models.
    Balakrishnan N; Milienos FS
    Biom J; 2020 Sep; 62(5):1208-1222. PubMed ID: 32175632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expectation maximization-based likelihood inference for flexible cure rate models with Weibull lifetimes.
    Balakrishnan N; Pal S
    Stat Methods Med Res; 2016 Aug; 25(4):1535-63. PubMed ID: 23740876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On a new piecewise regression model with cure rate: Diagnostics and application to medical data.
    Gómez YM; Gallardo DI; Leão J; Calsavara VF
    Stat Med; 2021 Dec; 40(29):6723-6742. PubMed ID: 34581460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vertical modeling: analysis of competing risks data with a cure fraction.
    Nicolaie MA; Taylor JMG; Legrand C
    Lifetime Data Anal; 2019 Jan; 25(1):1-25. PubMed ID: 29388073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the use of the modified power series family of distributions in a cure rate model context.
    Gallardo DI; Gómez YM; Gómez HW; de Castro M
    Stat Methods Med Res; 2020 Jul; 29(7):1831-1845. PubMed ID: 31559906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flexible Cure Rate Modeling Under Latent Activation Schemes.
    Cooner F; Banerjee S; Carlin BP; Sinha D
    J Am Stat Assoc; 2007 Jun; 102(478):560-572. PubMed ID: 21031152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Firth adjusted score function for monotone likelihood in the mixture cure fraction model.
    Almeida FM; Colosimo EA; Mayrink VD
    Lifetime Data Anal; 2021 Jan; 27(1):131-155. PubMed ID: 33184683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative binomial maximum likelihood expectation maximization (NB-MLEM) algorithm for reconstruction of pre-corrected PET data.
    Scipioni M; Santarelli MF; Giorgetti A; Positano V; Landini L
    Comput Biol Med; 2019 Dec; 115():103481. PubMed ID: 31627018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.